![Matthew Notarianni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Notarianni
Contatto Relazioni con gli Investitori presso
CERUS CORPORATION
Profilo
Matthew Notarianni currently works at Cerus Corp., as Senior Director-Investor Relations and MiMedx Group, Inc., as Head-Investor Relations from 2022.
Mr. Notarianni received his undergraduate degree from Marquette University.
Posizioni attive di Matthew Notarianni
| Società | Posizione | Inizio |
|---|---|---|
| CERUS CORPORATION | Contatto Relazioni con gli Investitori | - |
| MIMEDX GROUP, INC. | Contatto Relazioni con gli Investitori | 04/10/2022 |
Formazione di Matthew Notarianni
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
13
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Cerus Corp.
 Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Marquette University
 Marquette University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiMedx Group, Inc.
 MiMedx Group, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, and markets patent protected regenerative biomaterial products and bioimplants | Health Technology |
